Objectives: Postoperative respiratory adverse events (PRAEs) are known complications following adenotonsillectomy (AT). Clinical data at a single institution were reviewed to investigate the factors that may contribute to PRAEs in the postanesthesia care unit (PACU). The relationship between PRAEs in the PACU and escalation of care, defined as either an unplanned admission for outpatient surgery or unplanned pediatric intensive care unit (PICU) admission, was investigated. Methods: The perioperative records for all patients who underwent AT from 2016 to 2018 were reviewed. The surgical procedure was performed at both the main campus and the ambulatory surgery center in accordance with the institutional obstructive sleep apnea (OSA) guidelines. Patient characteristics and intraoperative medications were compared. Categorical variables were summarized as counts with percentages and compared using chi-square tests or Fisher's exact tests. Continuous variables were summarized as medians with interquartile ranges and compared using rank-sum tests. Multivariable logistic regression was performed to evaluate the association of intraoperative dosing with the occurrence of PRAEs.
| INTRODUCTION
In children with obstructive sleep apnea (OSA) or sleep-disordered breathing (SDB), adenotonsillectomy (AT) is a frequently chosen intervention to improve clinical and behavioral symptoms and overall quality of life. 1 As surgical intervention does not result in immediate resolution of symptoms, postoperative respiratory adverse events (PRAEs) still may occur. 2, 3 The incidence of PRAEs is higher in children having otolaryngological procedures than the general surgical population and can require escalation of care. 4 Various factors may increase the incidence of PRAEs including patient comorbid conditions, age, patient anatomical features, and perioperative choice of medications. 1, 5, 6 Opioid medications are the mainstay of analgesia for AT perioperatively, although they impact postoperative respiratory function. Thus, efforts to control pain with opioids may result in adverse respiratory events. 1 Children with OSA or SDB are more sensitive to opioids, which increases the potential for adverse respiratory events. 7, 8 Previous studies have demonstrated an increased risk of PRAEs with higher opioid doses. [9] [10] [11] [12] To limit opioid use during these procedures, nonopioid medications, such as acetaminophen and dexmedetomidine, are being employed more commonly to help control pain and agitation, while potentially minimizing the incidence of PRAEs. 13, 14 The American Academy of Otolaryngology-Head and Neck Surgery has provided recommendations concerning postoperative pain management in their clinical practice guidelines. 15 While many institutions have implemented protocols for caring for patients after AT, these protocols may vary, and reporting of outcomes remains limited.
Previous investigations have also sought to identify patient characteristics which are associated with PRAEs following AT. The most commonly identified risk factor is age, with patients <3 years of age at greater risk than older patients. 5, 16 Comorbid conditions may be contributory as sicker patients, defined by American Society of Anesthesiologists (ASA) physical status, tend to have an increased incidence of events. 5 One study identified African-American patients as having a higher likelihood of PRAEs relative to other ethnic groups. 17 Data on the role of weight/body mass index (BMI) are conflicting, with some sources citing weight/BMI as an independent risk factor while others have failed to prove its significance. 5, 16, 18 In the current study, clinical data from a single institution were retrospectively reviewed to investigate the factors which may contribute to PRAEs in the postanesthesia care unit (PACU), specifically intraoperative dosing of opioids and adjunctive medications and patient characteristics (age, gender, race/ethnicity, BMI, and ASA status). Additionally, we investigated the relationship of PRAEs in the PACU and subsequent events after admission as well as the need for escalation of care, defined as either an unplanned admission for outpatient surgery or an unplanned pediatric intensive care unit (PICU) admission for planned overnight admissions. We hypothesize that both patient characteristics and intraoperative medication administration will impact the incidence of PRAE; furthermore, we hypothesize that PRAE is typically confined to the PACU, with only the occasional occurrence after discharge from the PACU.
| METHODS
This study was approved by the Institutional Review Board at Nationwide Children's Hospital. Retrospectively patients, 2-18 years of age, were identified through a search of the electronic medical record database, who underwent AT between January 2016 and June 2018 at our institution. Given the infrequent occurrence of tonsillectomy in patients less than 2 years of age, the study did not include patients in that age group. At the time that the surgery was scheduled, admission status such as observational (2-4-hour postoperative stay) or overnight admission to either the inpatient ward or planned PICU admission was determined by the primary otolaryngologist and the pediatric anesthesiologist in alignment with institutional guidelines (see below). 19 Patients were excluded who had a recorded allergy to acetaminophen, dexmedetomidine, fentanyl, hydromorphone, or morphine, or who were missing data on study covariates. The primary outcome was the occurrence of PRAEs in PACU, defined as bronchospasm, laryngospasm, apnea/hypopnea, or hypoxemia/prolonged oxygen (O 2 )
requirement. An initial text search identified narrative text from the Electronic Medical Record (EMR) containing key phrases related to these events (Table 1) . Each event had a series of key phrases, identified in Table 1 , which were searched in the EMR. Positive search results were manually reviewed by the corresponding author and identified as either true positive or false positives. Event location was determined by the note's author (PACU nurse vs inpatient ward nurse), note's time relative to PACU discharge, or note type (PACU discharge note vs inpatient ward/PICU accept note). The significance of the event was then confirmed by the need for intervention or pharmacologic treatment. Bronchospasm was confirmed by the use of a bronchodilatory agent (albuterol, racemic epinephrine, ketamine).
Laryngospasm was confirmed by the use of positive pressure for an oxygen saturation (SpO 2 ) <90% or the administration of propofol or Each key phrase was placed between wild card characters, so that the record would be flagged regardless of the text surrounding the phrase. For example, "bronchodilat" would flag instances of both "bronchodilatory" and "bronchodilation."
succinylcholine. Apnea/hypopnea was defined as need for bag- of the patients who required escalated care were discharged the following day (Figure 1 ).
Intraoperative dosing of medications did not differ between those who experienced PRAEs and those who did not ( 
| DISCUSSION
Our data suggest that the incidence of PRAEs is low (2%) following AT in pediatric patients. In line with our hypothesis, patients who did not have problems in the PACU were unlikely to have events after discharge from the PACU. When PRAEs did occur, the spectrum of events included bronchospasm, laryngospasm, apnea, and hypoxemia, with the latter being most common. As previously reported, specific demographic features predicative of PRAEs included age, ASA physical status, and ethnic background. Intraoperative dosing and choice of medications did not impact the incidence of PRAE. Although the majority of patients who experience a PRAE in the PACU will have recovered completely prior to PACU discharge, 10% have a PRAE after PACU discharge. However, the majority of these events were persistent hypoxemia while sleeping, only requiring the administration of oxygen. Most of these hypoxemic events were short-lived and resolved within 24 hours, thereby allowing discharge the following day. Additionally, in the majority of cases, the acuity of such patients was such that they could be cared for on the inpatient ward with continuous pulse oximetry monitoring.
In a smaller subset of patients, the severity of the PRAE was significant enough to warrant escalation of care with admission to the PICU for monitoring of respiratory status. However, none of these patients required endotracheal intubation, and most were discharged home the following day. In many cases, this included a discharge home from the PICU. These findings underscore the need for ongoing close loop communication between providers (ie, pediatric otolaryngologist and pediatric anesthesiologist, pediatric anesthesiologist and PACU nurse, PACU nurse and floor/PICU nurse) regarding the events that occurred in PACU and what to be aware of while managing the patient beyond the PACU.
These unplanned admissions or escalations of care increase the cost of the hospital encounter and may not be reimbursed. At our institution, the charge of a PICU bed is roughly $6000 a night. While guidelines at our institution have successfully helped us to stratify which patients are better suited for an ambulatory setting vs the inpatient setting, future adjustments in these guidelines may be required as we are better able to stratify risk and identify patients at risk for PRAEs. 19 Currently, the presence of any one characteristic from the guidelines ( Table 2) Our data demonstrate that patient demographic features are more associated with PRAEs than the intraoperative medications administered. However, these findings should be taken in the context of the fact that this care was provided in a large, tertiary care children's hospital with fellowship trained pediatric anesthesiologists. As such, intraoperative opioid administration was generally limited with the frequent use of adjunctive medication. Our data support what multiple studies have shown. Age, race/ethnicity, and ASA physical status are independent risk factors for PRAEs. 5, 16, 17 Conversely, while there is literature which suggests that BMI also plays a role in PRAEs, our data did not find support this finding. 5, 16, 18 Although it did not reach statistical significance, the odds ratio (OR) associated with dexmedetomidine administration was 0.4, suggesting that it may decrease the incidence of PRAEs. Dexmedetomidine is an α 2 -adrenergic agonist that is commonly used perioperatively for sedation, analgesia, and anxiolysis. Given its mechanism of action, it may decrease emergence agitation allowing for a smoother emergence from anesthesia as well as decreasing perioperative opioid requirements.
As a retrospective study, there are specific limitations to the study. The study should be considered in the context of our institutional guidelines for caring for these patients which are in accordance with guidelines set forth by various organizational and surgical societies. We postulated that variations in the perioperative care of patients presenting for AT may impact the incidence of PRAEs. As the study was not meant to evaluate the impact of these guidelines, we did not collect data on patients before and after the institution of these guidelines. Additionally, we relied on a complete and accurate medical record when reviewing the patient records for PRAEs. Incomplete or inaccurate data in the record could potentially skew the results. The most likely inaccuracy would be the omission or downplaying of an event, especially if it was short lived or no harm came to the patient. Variance in reliability, while it can be controlled partially in a study's methodology, is still unavoidable. Two people may judge a potential event differently, based off their understanding of the event as provided by the medical record. Alternatively, an individual may judge a potential event differently when rating the event depending on when the event is reviewed.
Additionally, there is not a universal definition of a PRAE, thus allowing for variance in results, depending on the criteria and its interpretation. As there is no universal definition for PRAE, a better alternative may be to investigate each patient's specific respiratory parameters that necessitated interventions (SpO 2 , nadir and average; mode of oxygen therapy required; other therapies/interventions required, such as albuterol administration). However, such detail may not be possible in a retrospective review thereby necessitating a prospective evaluation which might limit patient numbers in the study cohort.
| CONCLUSIONS
In summary, PRAEs are a concerning but rare post-anesthetic complication in pediatric patients undergoing AT. For those patients experiencing PRAEs in the PACU, continued vigilance is suggested, as 15% had subsequent events that required escalation of postoperative care, to either an unplanned inpatient admission or the intensive care unit. However, in most cases, recurrence of PRAEs other than the need for ongoing oxygen administration was uncommon. As noted in previous studies, specific demographic features were associated with PRAEs. Future studies to further define these predictive features may be helpful in the development or refinement of institutional guidelines for postoperative care of such patients.
